Viewing Study NCT03012620


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-01-17 @ 4:54 AM
Study NCT ID: NCT03012620
Status: COMPLETED
Last Update Posted: 2024-02-28
First Post: 2017-01-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
Sponsor: UNICANCER
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module